드라베 증후군 치료 시장은 2024-2029년에 8억 4,950만 달러 증가하고, 예측기간 중 CAGR은 11.4%로 성장할 것으로 예측됩니다.
드라베 증후군 치료 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 특별 규제 지정 증가, 신제품 출시 증가, 드라베 증후군 치료를 위한 유전자 치료제의 발전에 힘입어 성장하고 있습니다.
| 시장 범위 |
| 기준연도 |
2025 |
| 종료연도 |
2029 |
| 예측 기간 |
2025-2029 |
| 성장 모멘텀 |
가속 |
| 전년대비 |
10.1% |
| CAGR |
11.4% |
| 증가액 |
8억 4,950만 달러 |
이 조사는 업계 주요 참가자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역별 분석에 따른 부문, 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.
이 보고서는 향후 수년간 드라베 증후군 치료제 시장의 성장을 가속하는 주요 요인 중 하나로 차세대 약물의 사용 증가를 꼽았습니다. 또한 생물 의학의 발전과 강력한 파이프라인은 시장의 큰 수요로 이어질 것입니다.
목차
제1장 개요
제2장 Technavio 분석
- 가격·수명주기·고객 구입 바스켓·채택률·구입 기준의 분석
- 인풋의 중요성과 차별화의 요인
- 혼란의 요인
- 촉진요인과 과제의 영향
제3장 시장 구도
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모 2024
- 시장 전망 2024-2029
제5장 시장 규모 실적
- 세계의 드라베 증후군 치료 시장 2019-2023
- 제품별 부문 분석 2019-2023
- 진단 방법별 부문 분석 2019-2023
- 유통 채널별 부문 분석 2019-2023
- 지역별 부문 분석 2019-2023
- 국가별 부문 분석 2019-2023
제6장 정성 분석
- AI의 영향 : 세계의 드라베 증후군 치료 시장
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 현황
제8장 시장 세분화 : 제품별
- 시장 부문
- 비교 : 제품별
- SGD : 시장 규모와 예측 2024-2029
- TGD : 시장 규모와 예측 2024-2029
- FGD : 시장 규모와 예측 2024-2029
- 시장 기회 : 제품별
제9장 시장 세분화 : 진단 방법별
- 시장 부문
- 비교 : 진단 방법별
- 자기공명영상 : 시장 규모와 예측 2024-2029
- 뇌파 검사 : 시장 규모와 예측 2024-2029
- SCN1A 유전자 검사 : 시장 규모와 예측 2024-2029
- 기타 : 시장 규모와 예측 2024-2029
- 시장 기회 : 진단 방법별
제10장 시장 세분화 : 유통 채널별
- 시장 부문
- 비교 : 유통 채널별
- 병원 약국 : 시장 규모와 예측 2024-2029
- 소매 약국 : 시장 규모와 예측 2024-2029
- E-Commerce : 시장 규모와 예측 2024-2029
- 기타 : 시장 규모와 예측 2024-2029
- 시장 기회 : 유통 채널별
제11장 고객 상황
제12장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측 2024-2029
- 유럽 : 시장 규모와 예측 2024-2029
- 아시아 : 시장 규모와 예측 2024-2029
- 세계의 기타 지역 : 시장 규모와 예측 2024-2029
- 미국 : 시장 규모와 예측 2024-2029
- 독일 : 시장 규모와 예측 2024-2029
- 중국 : 시장 규모와 예측 2024-2029
- 캐나다 : 시장 규모와 예측 2024-2029
- 프랑스 : 시장 규모와 예측 2024-2029
- 일본 : 시장 규모와 예측 2024-2029
- 영국 : 시장 규모와 예측 2024-2029
- 인도 : 시장 규모와 예측 2024-2029
- 이탈리아 : 시장 규모와 예측 2024-2029
- 멕시코 : 시장 규모와 예측 2024-2029
- 시장 기회 : 지역 상황별
제13장 촉진요인·과제·기회·억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 촉진요인과 과제의 영향
- 시장의 기회·억제요인
제14장 경쟁 구도
제15장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- AbbVie Inc.
- BIOCODEX SAS
- Encoded Therapeutics Inc.
- Epygenix Therapeutics Inc.
- H Lundbeck AS
- Jazz Pharmaceuticals Plc
- Johnson and Johnson Services Inc.
- Lupin Ltd.
- PTC Therapeutics Inc.
- Stoke Therapeutics Inc.
- Sun Pharmaceutical Industries Ltd.
- Supernus Pharmaceuticals Inc.
- Takeda Pharmaceutical Co. Ltd.
- UCB SA
- Viatris Inc.
제16장 부록
KSA
The dravet syndrome treatment market is forecasted to grow by USD 849.5 mn during 2024-2029, accelerating at a CAGR of 11.4% during the forecast period. The report on the dravet syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth in special regulatory designations, increasing new product launches, and advancements in genetic therapeutics for ds treatment.
| Market Scope |
|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 10.1% |
| CAGR | 11.4% |
| Incremental Value | $849.5 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's dravet syndrome treatment market is segmented as below:
By Product
By Diagnostic Methods
- Magnetic resonance imaging
- Electroencephalography
- SCN1A genetic testing
- Others
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- E-commerce
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increased use of new-generation drugs as one of the prime reasons driving the dravet syndrome treatment market growth during the next few years. Also, advances in biomedical sciences and strong pipeline will lead to sizable demand in the market.
The report on the dravet syndrome treatment market covers the following areas:
- Dravet Syndrome Treatment Market sizing
- Dravet Syndrome Treatment Market forecast
- Dravet Syndrome Treatment Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dravet syndrome treatment market vendors that include AbbVie Inc., BIOCODEX SAS, Encoded Therapeutics Inc., Epygenix Therapeutics Inc., H Lundbeck AS, Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Lupin Ltd., PTC Therapeutics Inc., Stoke Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Supernus Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., UCB SA, Viatris Inc., Xenon Pharmaceuticals Inc., and Zydus Lifesciences Ltd.. Also, the dravet syndrome treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Diagnostic Methods
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Dravet Syndrome Treatment Market 2019 - 2023
- Historic Market Size - Data Table on Global Dravet Syndrome Treatment Market 2019 - 2023 ($ million)
- 5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
- 5.3 Diagnostic Methods segment analysis 2019 - 2023
- Historic Market Size - Diagnostic Methods Segment 2019 - 2023 ($ million)
- 5.4 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Dravet Syndrome Treatment Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
- 8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
- 8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 8.3 SGDs - Market size and forecast 2024-2029
- Chart on SGDs - Market size and forecast 2024-2029 ($ million)
- Data Table on SGDs - Market size and forecast 2024-2029 ($ million)
- Chart on SGDs - Year-over-year growth 2024-2029 (%)
- Data Table on SGDs - Year-over-year growth 2024-2029 (%)
- 8.4 TGDs - Market size and forecast 2024-2029
- Chart on TGDs - Market size and forecast 2024-2029 ($ million)
- Data Table on TGDs - Market size and forecast 2024-2029 ($ million)
- Chart on TGDs - Year-over-year growth 2024-2029 (%)
- Data Table on TGDs - Year-over-year growth 2024-2029 (%)
- 8.5 FGDs - Market size and forecast 2024-2029
- Chart on FGDs - Market size and forecast 2024-2029 ($ million)
- Data Table on FGDs - Market size and forecast 2024-2029 ($ million)
- Chart on FGDs - Year-over-year growth 2024-2029 (%)
- Data Table on FGDs - Year-over-year growth 2024-2029 (%)
- 8.6 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Diagnostic Methods
- 9.1 Market segments
- Chart on Diagnostic Methods - Market share 2024-2029 (%)
- Data Table on Diagnostic Methods - Market share 2024-2029 (%)
- 9.2 Comparison by Diagnostic Methods
- Chart on Comparison by Diagnostic Methods
- Data Table on Comparison by Diagnostic Methods
- 9.3 Magnetic resonance imaging - Market size and forecast 2024-2029
- Chart on Magnetic resonance imaging - Market size and forecast 2024-2029 ($ million)
- Data Table on Magnetic resonance imaging - Market size and forecast 2024-2029 ($ million)
- Chart on Magnetic resonance imaging - Year-over-year growth 2024-2029 (%)
- Data Table on Magnetic resonance imaging - Year-over-year growth 2024-2029 (%)
- 9.4 Electroencephalography - Market size and forecast 2024-2029
- Chart on Electroencephalography - Market size and forecast 2024-2029 ($ million)
- Data Table on Electroencephalography - Market size and forecast 2024-2029 ($ million)
- Chart on Electroencephalography - Year-over-year growth 2024-2029 (%)
- Data Table on Electroencephalography - Year-over-year growth 2024-2029 (%)
- 9.5 SCN1A genetic testing - Market size and forecast 2024-2029
- Chart on SCN1A genetic testing - Market size and forecast 2024-2029 ($ million)
- Data Table on SCN1A genetic testing - Market size and forecast 2024-2029 ($ million)
- Chart on SCN1A genetic testing - Year-over-year growth 2024-2029 (%)
- Data Table on SCN1A genetic testing - Year-over-year growth 2024-2029 (%)
- 9.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 9.7 Market opportunity by Diagnostic Methods
- Market opportunity by Diagnostic Methods ($ million)
- Data Table on Market opportunity by Diagnostic Methods ($ million)
10 Market Segmentation by Distribution Channel
- 10.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
- 10.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 10.3 Hospital pharmacy - Market size and forecast 2024-2029
- Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
- 10.4 Retail pharmacy - Market size and forecast 2024-2029
- Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
- 10.5 E-commerce - Market size and forecast 2024-2029
- Chart on E-commerce - Market size and forecast 2024-2029 ($ million)
- Data Table on E-commerce - Market size and forecast 2024-2029 ($ million)
- Chart on E-commerce - Year-over-year growth 2024-2029 (%)
- Data Table on E-commerce - Year-over-year growth 2024-2029 (%)
- 10.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 10.7 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 12.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 12.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 12.11 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 12.12 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 12.13 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 12.14 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 12.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 12.16 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
- 13.1 Market drivers
- 13.2 Market challenges
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities/restraints
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
- 15.5 BIOCODEX SAS
- BIOCODEX SAS - Overview
- BIOCODEX SAS - Product / Service
- BIOCODEX SAS - Key offerings
- SWOT
- 15.6 Encoded Therapeutics Inc.
- Encoded Therapeutics Inc. - Overview
- Encoded Therapeutics Inc. - Product / Service
- Encoded Therapeutics Inc. - Key offerings
- SWOT
- 15.7 Epygenix Therapeutics Inc.
- Epygenix Therapeutics Inc. - Overview
- Epygenix Therapeutics Inc. - Product / Service
- Epygenix Therapeutics Inc. - Key offerings
- SWOT
- 15.8 H Lundbeck AS
- H Lundbeck AS - Overview
- H Lundbeck AS - Product / Service
- H Lundbeck AS - Key offerings
- SWOT
- 15.9 Jazz Pharmaceuticals Plc
- Jazz Pharmaceuticals Plc - Overview
- Jazz Pharmaceuticals Plc - Product / Service
- Jazz Pharmaceuticals Plc - Key news
- Jazz Pharmaceuticals Plc - Key offerings
- SWOT
- 15.10 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
- 15.11 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- 15.12 PTC Therapeutics Inc.
- PTC Therapeutics Inc. - Overview
- PTC Therapeutics Inc. - Product / Service
- PTC Therapeutics Inc. - Key offerings
- SWOT
- 15.13 Stoke Therapeutics Inc.
- Stoke Therapeutics Inc. - Overview
- Stoke Therapeutics Inc. - Product / Service
- Stoke Therapeutics Inc. - Key offerings
- SWOT
- 15.14 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
- 15.15 Supernus Pharmaceuticals Inc.
- Supernus Pharmaceuticals Inc. - Overview
- Supernus Pharmaceuticals Inc. - Product / Service
- Supernus Pharmaceuticals Inc. - Key offerings
- SWOT
- 15.16 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT
- 15.17 UCB SA
- UCB SA - Overview
- UCB SA - Product / Service
- UCB SA - Key offerings
- SWOT
- 15.18 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
